Formation Bio appoints Michael Ehlers as chief scientific officer and head of R&D
read at STAT ↗Positive
Formation Bio announced the hiring of Michael Ehlers as its new chief scientific officer and head of research and development.
Ehlers brings experience from founding and leading Ascidian Therapeutics, where he served as chief executive officer and president.
The appointment reflects Formation Bio's effort to strengthen scientific leadership and advance its drug development pipeline.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Up and down the ladder: The latest comings and goings”
read at STAT ↗470 words · retrieved Aug 14
comments(0)
5-min edit window · permanent after that